Growth delay studies in patients with multiple metastases.

Area of Science:

• Oncology
• Radiation Oncology
• Clinical Pharmacology

Background:

• Assessing cancer treatment efficacy requires robust methodologies.
• Individual patient variability complicates treatment response evaluation.
• Matched controls are ideal but often impractical in clinical settings.

Purpose of the Study:

• To introduce and validate a novel method for evaluating cancer treatment response.
• To investigate the efficacy of combining misonidazole with radiation therapy.
• To demonstrate the utility of using patients as their own controls for quantitative treatment assessment.

Main Methods:

• Utilizing patients with multiple measurable metastases as their own controls.
• Sequentially measuring metastatic regression, regrowth, and growth delay.
• Applying this method to three patients receiving radiation therapy with misonidazole.

Main Results:

• The method allows for quantitative assessment of treatment effects on metastases.
• The approach can discriminate between different doses of radiation therapy.
• Preliminary data suggest clinical information on tumor response to combined treatment.

Conclusions:

• Patients can serve as effective internal controls for treatment studies.
• This methodology offers a powerful tool for clinical trial design and drug evaluation.
• The study provides valuable insights into tumor response to radiation and misonidazole therapy.